Article Text

other Versions

Download PDFPDF
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients
  1. Christel Depienne (christel.depienne{at}
  1. INSERM U679, France
    1. Oriane Trouillard (oriane_tr{at}
    1. AP-HP, France
      1. Cécile SAINT-MARTIN (cecile.saint-martin{at}
      1. INSERM U679, France
        1. Isabelle AN ({at}
        1. AP-HP, France
          1. Delphine Bouteiller (delphine.bouteiller{at}
          1. INSERM U679, France
            1. Wassila Carpentier (wassila.carpentier{at}
            1. P3S platform, France
              1. Boris Keren (boris.keren{at}
              1. AP-HP, France
                1. Blandine Abert (b.abert{at}
                1. Service de neuropédiatrie, Hôpital Gatien de Clocheville, CHU Tours, France
                  1. Agnes Gautier (agnes.gautier{at}
                  1. Service de Neuropédiatrie , CHU Nantes , France, France
                    1. Stéphanie Baulac (baulac{at}
                    1. INSERM U679, France
                      1. Alexis Arzimanoglou (alexis.arzimanoglou{at}
                      1. Service d'Epileptologie Pédiatrique , University Hospitals of Lyon, France
                        1. Cécile Cazeneuve (cecile.cazeneuve{at}
                        1. AP-HP, France
                          1. Rima Nabbout (rimanabbout{at}
                          1. Département de Neuropédiatrie, AP-HP, Hôpital Necker-Enfants malades,, France
                            1. Eric Leguern (eric.leguern{at}
                            1. INSERM U679, France


                              Introduction. Mutations in the voltage-gated sodium channel SCN1A gene are the main genetic cause of Dravet syndrome (previously called Severe Myoclonic Epilepsy of Infancy or SMEI).

                              Objective and methods. Our objectives were to characterize in more detail the mutation spectrum associated with Dravet syndrome by screening a large series of 333 patients using both direct sequencing and Multiplex Ligation-dependent probe Amplification (MLPA). Additionally, we screened non-coding regions of the gene that are usually not investigated.

                              Results. SCN1A point mutations were identified in 228 patients, 161 of which were not previously reported. Missense mutations i) altering a highly conserved amino-acid of the protein, ii) transforming this conserved residue into a chemically dissimilar amino-acid and/or iii) belonging to ion transport sequences were the most frequent mutation type. MLPA analysis of the 105 patients without point mutation detected a heterozygous microrearrangement of SCN1A in 14 additional patients. Eight were private, partial deletions and six correspond to whole gene deletions ranging from 0.15 to 2.9 Mb deleting nearby genes. Finally, mutations in exon 5N and in untranslated regions of the SCN1A gene that were conserved during evolution were excluded in the remaining negative patients.

                              Conclusion. Altogether, these findings widely expand the SCN1A mutations spectrum identified and highlight the importance of screening the coding regions with both direct sequencing and a quantitative method. This mutation spectrum including whole gene deletions argues in favor of haploinsufficiency as the main mechanism responsible for Dravet syndrome.

                              Statistics from

                              Request Permissions

                              If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                              Supplementary materials